Results 191 to 200 of about 247,327 (296)

MicroRNA-200c Promotes Epithelial-Mesenchymal Transition of Lens Epithelial Cells by Activating the Yes-Associated Protein Signaling Pathway. [PDF]

J Ophthalmol
Wei YJ, Liu YA, Dai Y, Nan L, Song H, Li J.   +5 more
europepmc   +1 more source

A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Reliable potency assays are critical for ensuring the therapeutic consistency and manufacturing quality of mesenchymal stem/stromal cells (MSCs). Conventional assays based on soluble factor quantification often fail to capture extracellular matrix (ECM) remodeling capacity and exhibit high variability.
Shao Ying Tan, Mee‐Hae Kim, Masahiro Kino‐oka   +2 more
wiley   +1 more source

The Proto Type Galectin Drgal1-L2 from Zebrafish Hinders Infection by the Infectious Hematopoietic Necrosis Virus by Binding to Its Glycosylated Receptors on the Epithelial Cell Surface. [PDF]

Biomolecules
Abernathy K, Wang S, Feng C, Mancini J, Zong G, González-Montalbán N, Wang LX, Vasta GR.   +7 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Integrative plasma-to-spatial proteomics reveals fibroblast-associated signatures in liver metastatic breast cancer. [PDF]

Cancer Cell Int
Öcal E, Riese J, Schneider U, Kühnel MP, Jonigk D, Hirner-Eppeneder H, Corradini S, Öcal O, Goldberg SN, Seidensticker M, Ricke J, Wildgruber M, Alunni-Fabbroni M.   +12 more
europepmc   +1 more source

Targeting neutrophil extracellular traps in metabolic and immune niche: Nanomaterials for diabetes tissue regeneration

BMEMat, EarlyView.
The effects of NETs on regeneration of various diabetic tissues, and strategies targeting NETs for diabetes tissue regeneration. In the diabetic environment, NETs undergo complex metabolic and immune reprogramming, leading to dynamic changes in antibacterial and proinflammatory functions, and affecting regeneration of multiple systemic tissues.
Xinyi Jiang, Muxin Yue, Kai Mao, Boon Chin Heng, Noor Azlin Yahya, Yunsong Liu, Zheng Li   +6 more
wiley   +1 more source

Label-free proteomic profiling identifies ECM-related alterations across regeneration states in human peripheral axonal neuropathies. [PDF]

J Physiol Biochem
Damato M, Aboulouard S, La Pesa V, Gentile F, Lunghi G, Perrone M, Pranzo B, Chiricozzi E, Riva N, Fournier I, Romano A, Quattrini A, Salzet M, Maffia M.   +13 more
europepmc   +1 more source

Neurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges

BMEMat, EarlyView.
This figure illustrates various material strategies for neurovascularized bone regeneration, including electroactive scaffolds, ion‐loaded materials, drug delivery systems, surface modifications, cells/cell products, growth factors, and peptides. These approaches aim to synergistically promote the regeneration of neural, vascular, and bone tissues ...
Yixin Ma, Nan Jiang, Liyuan Chen, He Zhang, Xinjia Cai, Karan Gulati, Danqing He, Zhigang Cai, Yan Liu   +8 more
wiley   +1 more source

RETRACTION: Fibronectin Promotes Migration and Invasion of Ovarian Cancer Cells through Up-Regulation of FAK-PI3K/Akt Pathway. [PDF]

Cell Biol Int
europepmc   +1 more source

CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance. [PDF]

Cancer Immunol Res
King-Peoples TR, Keane JT, Lewis HS, Liu F, Brookens SK, Dagher OK, Parvathaneni K, Gardner BL, Ahmed A, Furth EE, Lal P, Posey AD.   +11 more
europepmc   +1 more source